| 注册
首页|期刊导航|生命科学仪器|哌拉西林他唑巴坦联合沙美特罗替卡松对慢性阻塞性肺疾病急性加重患者的临床疗效

哌拉西林他唑巴坦联合沙美特罗替卡松对慢性阻塞性肺疾病急性加重患者的临床疗效

孙华 陈康杰 刘炯

生命科学仪器2024,Vol.22Issue(6):64-66,3.
生命科学仪器2024,Vol.22Issue(6):64-66,3.DOI:10.11967/2024221222

哌拉西林他唑巴坦联合沙美特罗替卡松对慢性阻塞性肺疾病急性加重患者的临床疗效

Observation of the Effect of Biofeedback Electrical Stimulation Combined with WAFF Exercise in the Treatment of Uterine Scar Diverticulum

孙华 1陈康杰 1刘炯1

作者信息

  • 1. 湛江中心人民医院急诊医学科,广东 湛江 524000
  • 折叠

摘要

Abstract

Objective:To explore the clinical effect of piperacillin tazobactam combined with salmeterol and flutica-sone on acute exacerbation of chronic obstructive pulmonary disease(COPD).Methods:From January 2022 to Janu-ary 2024,100 COPD in acute exacerbation admitted to the emergency medicine department of Zhanjiang Central People's Hospital were studied and separated into the control group(n=50,piperacillin and tazobactam)and the observation group(n=50,salmeterol and fluticasone+piperacillin and tazobactam).The clinical therapeutic effect,pulmonary function and changes of inflammatory factors were compared.Results:The observation group had higher clinical therapeutic effect than the other group,better pulmonary function indexes after treatment,and lower levels of inflammatory indexes IL-6、hs-CRP and TNF-α(P<0.05).Conclusion:Piperacillin-tazobactam+salmeterol-fluticasone in acute exacerbation of COPD can improve the overall curative effect,improve the lung function index,reduce inflammatory factor levels and be beneficial to the prognosis.

关键词

哌拉西林他唑巴坦/沙美特罗替卡松/慢性阻塞性肺疾病急性加重/肺功能

Key words

Piperacillin and tazobactam/Salmeterol and fluticasone/Acute exacerbation of chronic obstructive pul-monary disease/Pulmonary function

分类

医药卫生

引用本文复制引用

孙华,陈康杰,刘炯..哌拉西林他唑巴坦联合沙美特罗替卡松对慢性阻塞性肺疾病急性加重患者的临床疗效[J].生命科学仪器,2024,22(6):64-66,3.

生命科学仪器

1671-7929

访问量0
|
下载量0
段落导航相关论文